Immunopathological Mechanisms and their Treatment
In planning any treatment, its effect on the disease process and on the patient generally must be weighed, and the disease must be considered in terms of three basic variables-causative agent, mechanism (or mechanisms), and host reaction. Recent rapid progress in immunology has permitted us to consider possible lines of treatment of immunopathological disease in terms of these variables. A further help has been the organization of the nomenclature of allergy by Coombs & Gell (1962) . This classification, with some examples, is outlined in Table 1 . Clearly the possible causative agents are numerous and each may be associated with reactions of more than one type, not only in different patients, but also in the same patient at the same time. In human serum sickness some aspects of Type 1 reaction occur as well as of Type 3 and in the fascinating group of patients with progressive pulmonary fibrosis following inhalation of various antigens, recently described by Pepys & Jenkins (1965) , serum and skin tests seem to imply a combination of both these reactions in the disease mechanism. The different reaction types depend on the nature of the antigen, the mode of entry, and on the host's own reaction. The 'causative agent' may also apparently be self, in autoallergic disease, but two words of warning are needed here. First, there is an important distinction between autoallergic (Blainey et al. 1960) . Though rapid steroid response is the usual experience in childhood nephrotic syndrome, we all know of exceptions, which are the rule in adults. There is expanding recognition of the role of other nonspecific modes of treatment in such patients. In the course of a comparative trial of another 'anti-inflammatory' reagent -hydroxychloroquine -for which there is some anecdotal evidence of effect in glomerulonephritis (Soothill & Hardwicke 1964) (Dixon et al. 1961) . He bled the rabbits twenty-four hours after each injection, and tested the serum for antigen and antibody. With little dose dependence, the serum of some of the rabbits had free antigen, some had free antibody and some had neither. Those with free antigen never got nephritis, those with antibody sometimes got acute nephritis which was transient, but those with neither got a progressive chronic glomerulonephritis which persisted even when the injections were stopped. I would describe the histology of their kidneys as lobular proliferative glomerulonephritis, and human disease can certainly look very similar histologically. This is essentially a chronic serum sickness situation, and there is reason to believe that the reaction depends on an antigen excess soluble complex with complement being an essential step in the tissue damage (Type 3 reaction). For reasons which will become apparent later I am anxious to investigate the possible roles of such a mechanism in human nephritis, and one feels that one should be able to detect this material in serum if it is relevant. The group of human disease which most closely resembles this animal situation, to my mind, is the lobular proliferative glomerulonephritis associated with the nephrotic syndrome in Nigerian children thought to be associated with Plasmodium malarik infection (Gilles & Hendrickse 1963) . By a combination of immunological techniques we have been able to identify a remarkably homogeneous group of children in this population who seem to have an allergic complement-dependent disease. Using the complement antigen P,3c as a marker to detect macromolecular complexes separated by G-200 Sephadex gel filtration, we believe we have obtained evidence of presence of such complexes in the sera of these patients (Soothill & Hendrickse 1967 the possibility must be considered of curing these children by administering more antigen, perhaps in adjuvant, to make them rapidly better antibody producers so that they will behave like Dixon's good antibody-producing rabbits, getting an acute nephritis-like disease, which should be self-limiting.
I have ended with hypothesis because I think it illustrates the possibilities of application of modern immunological knowledge to the cure of immunopathological disease, as well as of infective disease. First, we must test it in the situation of the malarial nephrotic syndrome, and then try to establish what other forms of glomeiulonephritis are soluble complex disease, and find the antigens responsible for each one of these in order to attempt a similar line of treatment. Next, we must study the role of this type of mechanism in other disease processes to see if they are also similarly treatable by antigen specific means. I suspect that the treatment of autoallergic disease will for a long time be confined to nonspecific immunosuppressive and anti-inflammatory measures, but, even here, antigen elimination has been attempted with some evidence of effect (Lachmann 1967) . In planning nonspecific treatment let us always recall that much disease could conceivably be approached in an antigen-specific manner and this is much more likely to be both effective and safe.
